Antibiotice S.A. (BVB:ATB)

Antibiotice Revenue

Antibiotice had revenue of 164.90M RON in the quarter ending June 30, 2026, a decrease of -4.70%. This brings the company's total for the last twelve months to 616.58M, down -6.43% year-over-year. In the year 2025, Antibiotice had annual revenue of 647.25M, down -4.48%. That makes Antibiotice the 20,799th largest company in the world by revenue and 30th in Romania.

• Revenue (ttm): 616.58M
• Revenue Growth: -6.43%
• P/S Ratio: 2.09
• Revenue / Employee: 455.04K
• Employees: 1,356
• Market Cap: 1.29B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Romania 379.02M 58.7%
• Foreign 266.26M 41.3%

Fiscal year ended Dec 31, 2025 See the full Antibiotice breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	647.25M	-30.33M	-4.48%
Dec 31, 2024	677.58M	62.29M	10.12%
Dec 31, 2023	615.29M	124.07M	25.26%
Dec 31, 2022	491.22M	122.94M	33.38%
Dec 31, 2021	368.28M	27.41M	8.04%

Data Source: S&P Global Market Intelligence Last updated: Aug 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error